| Carson Tahoe Physician Clinics | |
|
925 Ironwood Dr Suite 2103 Minden NV 89423-5178 | |
| (775) 445-7885 | |
| Not Available |
| Full Name | Carson Tahoe Physician Clinics |
|---|---|
| Speciality | Family Medicine |
| Location | 925 Ironwood Dr, Minden, Nevada |
| Authorized Official Name and Position | Yolanda Romo (ADMIN ASSIST) |
| Authorized Official Contact | 7752833096 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Carson Tahoe Physician Clinics 2874 N Carson St Suite 200 Carson City NV 89706-0251 Ph: (775) 283-3096 | Carson Tahoe Physician Clinics 925 Ironwood Dr Suite 2103 Minden NV 89423-5178 Ph: (775) 445-7885 |
| NPI Number | 1518267301 |
|---|---|
| Provider Enumeration Date | 10/26/2010 |
| Last Update Date | 10/26/2010 |
| Medicare PECOS PAC ID | 1153479027 |
|---|---|
| Medicare Enrollment ID | O20110315000144 |
News Archive
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
Alcohol intake was associated with higher rates of invasive melanoma among white men and women.
A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
Republican leaders in the House have scheduled votes Wednesday on bills that would delay implementation of the overhaul's employer and individual mandates. According to the Associated Press, these efforts mark the 38th time the GOP majority has tried to undo the law or major provisions.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518267301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | 4143 (Nevada) | Primary |
| Provider Name | David M Baker |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1063464279 PECOS PAC ID: 0749204246 Enrollment ID: I20060608000169 |
News Archive
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
Alcohol intake was associated with higher rates of invasive melanoma among white men and women.
A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
Republican leaders in the House have scheduled votes Wednesday on bills that would delay implementation of the overhaul's employer and individual mandates. According to the Associated Press, these efforts mark the 38th time the GOP majority has tried to undo the law or major provisions.
› Verified 5 days ago
| Provider Name | Nathan Hung Ho |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1841220845 PECOS PAC ID: 5698878676 Enrollment ID: I20070312000533 |
News Archive
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
Alcohol intake was associated with higher rates of invasive melanoma among white men and women.
A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
Republican leaders in the House have scheduled votes Wednesday on bills that would delay implementation of the overhaul's employer and individual mandates. According to the Associated Press, these efforts mark the 38th time the GOP majority has tried to undo the law or major provisions.
› Verified 5 days ago
News Archive
Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).
Alcohol intake was associated with higher rates of invasive melanoma among white men and women.
A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements in perceived quality of prostate cancer care.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed dendritic cell vaccines in a pilot study of tumor vaccination in patients with metastatic or recurrent pediatric solid tumors and altered T cell homeostasis, including patients with Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, neuroblastoma, synovial cell sarcoma, desmoplastic small round cell tumor, undifferentiated sarcoma, and embryonal sarcoma.
Republican leaders in the House have scheduled votes Wednesday on bills that would delay implementation of the overhaul's employer and individual mandates. According to the Associated Press, these efforts mark the 38th time the GOP majority has tried to undo the law or major provisions.
› Verified 5 days ago
Carson Tahoe Physician Clinics - Minden #3 Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 925 Ironwood Dr, Suite 2105, Minden, NV 89423 Phone: 775-445-7745 Fax: 775-782-0073 | |
Merry Medical Team Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1649 Lucerne St, Ste A & B, Minden, NV 89423 Phone: 775-782-1603 Fax: 775-782-3427 | |
Va Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1779 Lantana Dr, Minden, NV 89423 Phone: 775-450-5707 | |
Minden Family Medicine And Complete Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1649 Lucerne St, Suite A & B, Minden, NV 89423 Phone: 775-782-1603 Fax: 775-782-3417 | |
Mountainview Medical Associates Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1701 County Rd Ste H, Minden, NV 89423 Phone: 775-782-3933 Fax: 775-782-1127 | |
Sanchez Adult Medical Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1661 Lucerne St, Minden, NV 89423 Phone: 775-392-3232 Fax: 775-392-3233 | |
Hillbrick Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1685 Us Highway 395 N, Ste A, Minden, NV 89423 Phone: 775-783-0624 |